SCHEMBL6153513

SCHEMBL6153513

CCOc1cc(NC2CCNCC2)ccc1C(N)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.46
MAPT P10636 1/20 0.44
TDP1 Q9NUW8 1/20 0.43
AURKA O14965 1/20 0.42
RPS6KB1 P23443 1/20 0.42
MKNK1 Q9BUB5 2/20 0.42
MKNK2 Q9HBH9 2/20 0.42
P2RX7 Q99572 1/20 0.41
PARP15 Q460N3 1/20 0.40
PARP10 Q53GL7 1/20 0.40
SIRT2 Q8IXJ6 1/20 0.39
KIT P10721 1/20 0.39
FLT3 P36888 1/20 0.39
IRAK4 Q9NWZ3 2/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
ALDH1A1 P00352 1/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6155360 0.91 MAPT (0.46) SYKMAPTAURKARPS6KB1MKNK1
SCHEMBL6153679 0.86 HTR4 (0.48) SYKAURKARPS6KB1MKNK1MKNK2
SCHEMBL6154413 0.83 IRAK4 (0.48) MKNK1MKNK2IRAK4
SCHEMBL6154140 0.82 HTR4 (0.45) SYKRPS6KB1PARP15PARP10KIT
SCHEMBL6153310 0.81 EPHX1 (0.48) SYKAURKARPS6KB1MKNK1MKNK2
SCHEMBL6155049 0.80 FLT3 (0.44) SYKAURKARPS6KB1P2RX7SIRT2
SCHEMBL6154946 0.79 LTA4H (0.52) SLC6A2SLC6A3ALDH1A1KDM4EMEN1
SCHEMBL6153421 0.78 AURKA (0.45) SYKAURKARPS6KB1P2RX7SIRT2
SCHEMBL6156769 0.77 ROCK2 (0.47) SYKAURKARPS6KB1P2RX7PARP15
SCHEMBL6153710 0.77 RPS6KB1 (0.44) SYKAURKARPS6KB1P2RX7SIRT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050182040-A1 Benzamide derivatives DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-18 US disclosed
EP-1500643-A1 BENZAMIDE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2005-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182040-A1 Benzamide derivatives ROCK1, ROCK2, NHERF1 SYK 1613/4885MAPT 4237/4885TDP1 3782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.